Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

BRE12-158

A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer.

Status: Open to Accrual

This study will test the theory that therapy designed for each individual’s tumor will improve outcomes over standard of care in a population that needs a better standard.

  • Condition: Triple Negative (ER-/PR-/HER2-) Invasive Breast Cancer
  • Intervention:
    • Drug: Genomically Directed Monotherapy
    • Other: Observation/Standard Therapy
  • Phase: Phase 2

Read a news release about this trial.

For full description, see clinical trials.gov.

Project Manager: Donna LaPlaca Sullivan, dsullivan@hoosiercancer.org; (317) 634-5842, ext. 40.